Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population

Sunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase 2a COURSE trial of Tezspire (tezepelumab-ekko) for severe chronic obstructive pulmonary disease (COP

Benzinga02:38

Smart Money Is Betting Big In UNH Options

Investors with a lot of money to spend have taken a bearish stance on UnitedHealth Group (NYSE:UNH).And retail traders should know.We noticed this today when the positions showed up on publicly availa

Benzinga01:01

AstraZeneca, Amgen Release Mid-stage Data on Tezspire for COPD

Seeking Alpha00:49

Witness history! The Dow closed above 40,000 points for the first time. Apart from constituent stocks, these ETFs are also worth watching

Buffett once said, “By regularly investing in index funds, an amateur investor who doesn't understand anything can often beat most professional investors.”

Futu NewsMay 20 19:05

Reported Sunday, AstraZeneca And Amgen's TEZSPIRE Shows Potential For Future Chronic Obstructive Pulmonary Diseasetreatment In New Data Presented At ATS 2024

Late-breaking results from the Phase IIa COURSE trial provide insight into TEZSPIRE's impact on COPD exacerbations in patients with a broad range of eosinophil levelsThe Phase IIa COURSE trial was a p

BenzingaMay 20 12:55

Cloud Stock List (Weekly) (Part 1)

○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1379＞ Hokto 1831 1797.75 1827 ＜2121＞ MIXI 2765 2427 2587 ＜2331＞ ALSOK 914 875.25 813 ＜2372＞ ILOM G 　

Fisco JapanMay 20 06:54